ISDA

Deposition Date 2008-02-05

Release Date 2008-04-22

Last Version Date 2023-08-30

Entry Detail

PDB ID:

3C6T

Keywords:

TRANSFERASE

Title:

Crystal Structure of HIV Reverse Transcriptase in complex with inhibitor 14

Biological Source:

Source Organism:

HIV-1 M:B_HXB2R (Taxon ID: 11706)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.70 Å

R-Value Free:

0.28

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Reverse transcriptase
Gene (Uniprot):gag-pol
Chain IDs:A
Chain Length:563
Number of Molecules:1
Biological Source:HIV-1 M:B_HXB2R

UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Reverse transcriptase
Gene (Uniprot):gag-pol
Chain IDs:B
Chain Length:443
Number of Molecules:1
Biological Source:HIV-1 M:B_HXB2R

UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075

Ligand Molecules

M14

Primary Citation

The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations.

Tucker, T.J, Saggar, S, Sisko, J.T, Tynebor, R.M, Williams, T.M, Felock, P.J, Flynn, J.A, Lai, M.T, Liang, Y, McGaughey, G, Liu, M, Miller, M, Moyer, G, Munshi, V, Perlow-Poehnelt, R, Prasad, S, Sanchez, R, Torrent, M, Vacca, J.P, Wan, B.L, Yan, Y.Show

Bioorg.Med.Chem.Lett. 18 2959 2966 (2008)

PMID: 18396399 DOI: 10.1016/j.bmcl.2008.03.064

Abstact

Using a combination of traditional Medicinal Chemistry/SAR analysis, crystallography, and molecular modeling, we have designed and synthesized a series of novel, highly potent NNRTIs that possess broad antiviral activity against a number of key clinical mutations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures